| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ACHILLION PHARMACEUTICALS IN | 420,000 | 4,532,000 | 0.69% | ||
| 52 | LANNET INC COM NEW | 107,480 | 4,312,000 | 0.66% | ||
| 53 | BAXTER INTL INC | 110,000 | 4,197,000 | 0.64% | ||
| 54 | ANTHEM INC | 30,000 | 4,183,000 | 0.64% | ||
| 55 | BRISTOL MYERS SQUIBB CO | 60,000 | 4,127,000 | 0.63% | ||
| 56 | HCA HOLDINGS INC | 60,000 | 4,058,000 | 0.62% | ||
| 57 | NEUROCRINE BIOSCIE COM USD0.001 | 65,000 | 3,677,000 | 0.56% | ||
| 58 | NEKTAR THERAPEUTICS COM | 216,000 | 3,640,000 | 0.55% | ||
| 59 | CERNER CORP | 60,000 | 3,610,000 | 0.55% | ||
| 60 | PFIZER INC | 110,000 | 3,551,000 | 0.54% | ||
| 61 | AGIOS PHARMACEUTICALS INC | 54,000 | 3,506,000 | 0.53% | ||
| 62 | NOVADAQ TECHNOLOGIES INC | 250,000 | 3,185,000 | 0.49% | ||
| 63 | MERCK & CO INC | 60,000 | 3,169,000 | 0.48% | ||
| 64 | HOLOGIC INC | 81,000 | 3,134,000 | 0.48% | ||
| 65 | MASIMO CORP | 75,000 | 3,113,000 | 0.47% | ||
| 66 | ARIAD PHARMACEUTICALS ORD (NMS) | 495,000 | 3,094,000 | 0.47% | ||
| 67 | SEATTLE GENETICS INC | 68,000 | 3,052,000 | 0.47% | ||
| 68 | MEDIVATION INC | 63,000 | 3,045,000 | 0.46% | ||
| 69 | VARIAN MED SYS INC | 37,000 | 2,990,000 | 0.46% | ||
| 70 | LILLY ELI & CO | 35,000 | 2,949,000 | 0.45% | ||
| 71 | THERMO FISHER SCIENTIFIC INC | 20,000 | 2,837,000 | 0.43% | ||
| 72 | NOVAVAX INC COM | 325,000 | 2,727,000 | 0.42% | ||
| 73 | MACROGENICS INC | 83,000 | 2,571,000 | 0.39% | ||
| 74 | QIAGEN NV | 91,500 | 2,530,000 | 0.39% | ||
| 75 | CELLDEX THERAPEUTICS INC NEW | 160,000 | 2,509,000 | 0.38% | ||
| 76 | COOPER COS INC | 18,500 | 2,483,000 | 0.38% | ||
| 77 | RADIUS HEALTH INCORPORATED COM NEW | 40,000 | 2,462,000 | 0.38% | ||
| 78 | GLOBUS MED INC | 87,700 | 2,440,000 | 0.37% | ||
| 79 | TELEFLEX INC | 18,557 | 2,439,000 | 0.37% | ||
| 80 | NUVASIVE INC | 45,000 | 2,435,000 | 0.37% | ||
| 81 | HEALTHCARE SVCS GRP INC | 65,000 | 2,267,000 | 0.35% | ||
| 82 | ALNYLAM PHARMACEUTICALS INC | 24,000 | 2,259,000 | 0.34% | ||
| 83 | ZELTIQ AESTHETICS INC | 75,000 | 2,140,000 | 0.33% | ||
| 84 | PROTHENA CORP PLC | 31,000 | 2,111,000 | 0.32% | ||
| 85 | INTERCEPT PHARMACEUTICALS INCORPORATED | 13,500 | 2,016,000 | 0.31% | ||
| 86 | BLUEBIRD BIO INC COM | 29,000 | 1,862,000 | 0.28% | ||
| 87 | CLOVIS ONCOLOGY INC | 52,500 | 1,838,000 | 0.28% | ||
| 88 | STERICYCLE INC | 15,000 | 1,809,000 | 0.28% | ||
| 89 | PTC THERAPEUTICS INC | 55,000 | 1,782,000 | 0.27% | ||
| 90 | INOVIO PHARMACEUTICALS INC | 265,000 | 1,781,000 | 0.27% | ||
| 91 | Wright Medical Group NV | 70,309 | 1,700,000 | 0.26% | ||
| 92 | JUNO THERAPEUTICS INC COM | 37,000 | 1,627,000 | 0.25% | ||
| 93 | ACADIA PHARMACEUTICALS INC COM | 45,000 | 1,604,000 | 0.24% | ||
| 94 | WELLCARE HEALTH PLANS INC | 20,000 | 1,564,000 | 0.24% | ||
| 95 | UNITED THERAPEUTICS CORP DEL | 9,300 | 1,456,000 | 0.22% | ||
| 96 | DAVITA INC | 20,000 | 1,394,000 | 0.21% | ||
| 97 | INFINITY PHARMACEUTICALS INC | 160,000 | 1,256,000 | 0.19% | ||
| 98 | LABORATORY CORP AMER HLDGS | 10,000 | 1,236,000 | 0.19% | ||
| 99 | ANGIODYNAMICS INC | 100,000 | 1,214,000 | 0.18% | ||
| 100 | ULTRAGENYX PHARMACEUTICAL INC COM | 10,000 | 1,122,000 | 0.17% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-014462, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
